| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 215,967 | 224,731 | 196,809 | 289,920 | | Cost of Revenue | 187,734 | 201,303 | 174,776 | 225,364 | | | Gross Profit | 28,233 | 23,428 | 22,033 | 64,556 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 19,580 | 17,121 | 22,733 | 21,293 | | Non Recurring |
-
|
-
|
-
| 1,124 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,653 | 6,307 | (700) | 42,139 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (17,331) | 202 | 279 | 798 | | Earnings Before Interest And Taxes | (8,678) | 6,509 | (421) | 42,937 | | Interest Expense | 10,480 | 11,812 | 8,541 | 6,675 | | Income Before Tax | (19,158) | (5,303) | (8,962) | 36,262 | | Income Tax Expense | (6,991) | (1,707) | (3,504) | 12,758 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,167) | (3,596) | (5,458) | 23,504 | | | Non-recurring Events | | Discontinued Operations | (5) | (172) |
-
| 189 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,172) | (3,768) | (5,458) | 23,693 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,172) | ($3,768) | ($5,458) | $23,693 |
|
0.51% Nasdaq 
Income Statement
